| CAS ID: | 113-24-6 |
| Molecular Formula: | C3H3NaO3 |
| Molecular Weight: | 88.1 g/mol |
| Monoisotopic Mass: | 88.016 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | Sodium 2-Oxo-Propionate | Sodium 2-Oxopropanoate |
| Analysis: | Drug repositioning mechanism analysis |
Trial Record 1
| ClinicalTrial ID | NCT00308243 | Disease | Cystic fibrosis |
| Phase | Phase 1 | Status | Completed |
| First Received | March 29, 2006 | Last Verified | July 19, 2011 |
| Sponsor | Emphycorp | ||
Trial Record 2
| ClinicalTrial ID | NCT00332215 | Disease | Cystic fibrosis |
| Phase | Phase 1 | Status | Terminated |
| First Received | June 1, 2006 | Last Verified | December 1, 2008 |
| Sponsor | University of Minnesota - Clinical and Translational Science Institute | ||
| PubChem: | 23662274 |
| ChEMBL: | CHEMBL181886 |